Use of [(177)Lu]Lu-DOTA-TATE in the treatment of gastroenteropancreatic neuroendocrine tumours: Results of a UK cost-effectiveness modelling study.
- DOI
- 10.1016/j.ejcsup.2021.06.003
- Published
- 2021 Nov
- Container
- EJC supplements : EJC : official journal of EORTC, European Organization for Research and Treatment of Cancer ... [et al.]
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ejcsup.2021.06.003,
title = {Use of [(177)Lu]Lu-DOTA-TATE in the treatment of gastroenteropancreatic neuroendocrine tumours: Results of a UK cost-effectiveness modelling study.},
author = {Glover M and Caplin M and Leeuwenkamp OR and Longworth L},
year = {2021},
journal = {EJC supplements : EJC : official journal of EORTC, European Organization for Research and Treatment of Cancer ... [et al.]},
doi = {10.1016/j.ejcsup.2021.06.003},
url = {https://doi.org/10.1016/j.ejcsup.2021.06.003}
}RIS
TY - JOUR TI - Use of [(177)Lu]Lu-DOTA-TATE in the treatment of gastroenteropancreatic neuroendocrine tumours: Results of a UK cost-effectiveness modelling study. AU - Glover M AU - Caplin M AU - Leeuwenkamp OR AU - Longworth L PY - 2021 JO - EJC supplements : EJC : official journal of EORTC, European Organization for Research and Treatment of Cancer ... [et al.] DO - 10.1016/j.ejcsup.2021.06.003 UR - https://doi.org/10.1016/j.ejcsup.2021.06.003 ER -
APA
M, G., M, C., OR, L., & L, L. (2021). Use of [(177)Lu]Lu-DOTA-TATE in the treatment of gastroenteropancreatic neuroendocrine tumours: Results of a UK cost-effectiveness modelling study.. EJC supplements : EJC : official journal of EORTC, European Organization for Research and Treatment of Cancer ... [et al.]. https://doi.org/10.1016/j.ejcsup.2021.06.003
Source records
- pubmed · retrieved 2026-09-26T02:04:37.979Z